Our data demonstrate that Igfbp5 expression levels in cardiac vascular endothelial cells are consistently elevated throughout the course of diabetes progression, indicating that Igfbp5 is an important target role for the treatment of diabetic injury in both hearts and kidneys. The gene discussed is IGFBP5; the disease is diabetes mellitus.